Page last updated: 2024-08-21

alpha-aminopyridine and Cancer of Kidney

alpha-aminopyridine has been researched along with Cancer of Kidney in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cao, J; Chen, D; Sun, X; Zhang, X1
Higo, H; Hotta, K; Ichihara, E; Kano, H; Kayatani, H; Kiura, K; Kubo, T; Maeda, Y; Makimoto, G; Matsubara, T; Ninomiya, K; Ninomiya, T; Nishii, K; Ohashi, K; Rai, K; Sato, A; Tabata, M; Takata, M; Tomida, S; Toyooka, S; Watanabe, H1
Alarcon, S; Collins, J; Doroshow, JH; Kinders, RJ; Kummar, S; Lee, MJ; Park, SR; Pfister, T; Piekarz, R; Speranza, G; Steinberg, SM; Trepel, JB; Wang, L; Wright, JJ1
de Gramont, A; Dos Santos, C; Faivre, S; Raymond, E; Riveiro, ME; Serova, M; Slimane, K; Tijeras-Raballand, A1
Bellmunt, J; Choueiri, TK; De Velasco, G; Harshman, L; Hirsch, M; McDermott, DF; McKay, RR; Rosenberg, JE; Signoretti, S; Sweeney, C; Vaishampayan, U; Van Allen, EM; Walsh, M; Werner, L1
Abu Aboud, O; Argueta, C; Baloglu, E; Chen, CH; Senapedis, W; Weiss, RH1

Trials

2 trial(s) available for alpha-aminopyridine and Cancer of Kidney

ArticleYear
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:4

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Aminopyridines; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cohort Studies; Colorectal Neoplasms; Endothelial Cells; Female; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Morpholines; Neoplasms; Oxazines; Pheochromocytoma; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Thyroid Neoplasms

2013
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.
    Cancer, 2016, Aug-01, Volume: 122, Issue:15

    Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Molecular Targeted Therapy; Morpholines; Neoplasm Metastasis; Treatment Outcome; Vascular Endothelial Growth Factor A

2016

Other Studies

4 other study(ies) available for alpha-aminopyridine and Cancer of Kidney

ArticleYear
Inhibition of the CDK4/6-Cyclin D-Rb Pathway by Ribociclib Augments Chemotherapy and Immunotherapy in Renal Cell Carcinoma.
    BioMed research international, 2020, Volume: 2020

    Topics: Aminopyridines; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinases; Humans; Kidney Neoplasms; Male; Mice; Mice, SCID; Protein Kinase Inhibitors; Purines; Signal Transduction; Xenograft Model Antitumor Assays

2020
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019, Volume: 14, Issue:11

    Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cell Line, Tumor; Crizotinib; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Humans; Kidney Neoplasms; Lactams; Lactams, Macrocyclic; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Middle Aged; Mutation; Piperidines; Pyrazoles; Xenograft Model Antitumor Assays

2019
Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:5

    Topics: Aminopyridines; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Everolimus; Humans; Imidazoles; Indoles; Kidney Neoplasms; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Morpholines; Multiprotein Complexes; Niacinamide; Phenylurea Compounds; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Pyrroles; Quinolines; Signal Transduction; Sirolimus; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases

2013
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:9

    Topics: Acrylamides; Aminopyridines; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Humans; Kidney Neoplasms; Male; Mice; Molecular Targeted Therapy; NAD; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

2016